Related Experiment Videos
Pseudomonas aeruginosa antibody detection in cystic fibrosis patients
M Trancassini1, D De Vito, S Quattrucci
1Institute of Microbiology, Medical School, University of Rome La Sapienza, Rome, Italy.
Insights
Early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis patients is crucial. An immunoenzymatic test detecting antibody responses can aid in early detection, even without bacteriological evidence in young children.
Area of Science:
- Medical Microbiology
- Immunology
- Pediatric Pulmonology
Background:
- Chronic Pseudomonas aeruginosa infection significantly impacts prognosis in cystic fibrosis (CF) patients.
- Early diagnosis is key to delaying chronic infection and improving patient outcomes.
- Diagnosing infection in young CF patients is challenging due to limited clinical and bacteriological evidence.
Purpose of the Study:
- To evaluate an immunoenzymatic system for detecting antibody responses to Pseudomonas aeruginosa antigens.
- To assess the utility of serological screening for early diagnosis in young CF patients.
Main Methods:
- An immunoenzymatic system was used to measure antibody levels against three purified P. aeruginosa antigens: alkaline protease, elastase, and exotoxin A.
- Antibody responses were analyzed in 40 cystic fibrosis patients (20 infected, 20 uninfected).
- Serological results were compared with bacteriological findings for each patient.
Main Results:
- The immunoenzymatic system effectively detected antibody responses against P. aeruginosa antigens.
- Serological screening demonstrated utility in identifying P. aeruginosa infection in young CF patients.
- Positive serological results were observed in patients lacking clear bacteriological evidence of infection.
Conclusions:
- Immunoenzymatic antibody detection offers a valuable tool for early P. aeruginosa diagnosis in cystic fibrosis.
- Serological screening can supplement bacteriological methods, especially in young patients.
- Early detection through serology may facilitate timely intervention to prevent chronic infection.
Abstract:
Chronic respiratory infection due to Pseudomonas aeruginosa remains the most important prognostic factor in cystic fibrosis patients. One method to lengthen the patient's life is to extend the initial state of the illness with an early diagnosis, before Ps. aeruginosa infection becomes chronic. Often this is difficult because of the young age of the patients. This study tested an immunoenzymatic system to evaluate antibody response against three Ps. aeruginosa purified antigens, alkaline protease, elastase and exotoxin A. We studied 40 patients with cystic fibrosis, 20 affected and 20 unaffected by apparent Ps. aeruginosa infection, also from the bacteriological point of view. Serological and bacteriological results were compared for each patient and showed that serological screening can be useful in young subjects, who often have no bacteriological evidence of Ps. aeruginosa colonization.